For research use only. Not for therapeutic Use.
<p style=/line-height:25px/>BCX4430 is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile.<br>IC50 value:<br>Target: RdRp inhibitor<br>BCX4430, a novel synthetic adenosine analogue, inhibits infection of distinct filoviruses in human cells. Interfering with the replication process is a well-established antiviral strategy that has been successfully exploited in developing such life-saving drugs as the nucleoside inhibitors of HIV and acyclovir for herpes simplex complex. BCX4430 may be suitable for administration by intravenous (IV), intramuscular (IM), and oral (PO) routes.</p>
| Catalog Number | I002705 |
| CAS Number | 222631-44-9 |
| Molecular Formula | C11H16ClN5O3 |
| Purity | ≥95% |
| Target | RdRp inhibitor |
| Solubility | H2O: ≥ 41 mg/mL |
| Storage | Store at RT |
| Reference | <p style=/line-height:25px/> |
